News

Mauna Kea Technologies reports fourth quarter and full year 2019 sales

29 January 2020

 Full Year 2019 total sales up 10% 
Sales to clinical customers up 27%, driven by 89% growth in consumables sales related to pay-per-use program 

Fourth Quarter total sales down 20% 
Fourth quarter sales to clinical customers down 18%, driven by 29% increase in consumables sales which partially offset expected year-over-year decline in US capital sales 

Latest News

Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 

Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 

Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update 

Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update 

Mauna Kea Technologies announces entrance into exclusive negotiations for a licensing agreement for Cellvizio® in an important therapeutic area with a major industry player 

Mauna Kea Technologies announces entrance into exclusive negotiations for a licensing agreement for Cellvizio® in an important therapeutic area with a major industry player